INVESTING·MAPS Value Chain Collection
中文

Investment Maps · 2026 · US / HK / A-Shares

Six Value Chain Maps
to Navigate US, HK & A-share Markets

Each map profiles leading companies along the upstream-to-downstream value chain — core products, moat ratings, investment thesis, key metrics & risks — plus ETF tools, decision signal calendars and risk matrices. Data as of July 2026.

6maps Value Chain Maps
138+ Company Profiles
3markets US · HK · A-shares
2lang 中文 · English

Select a Map · 选择图谱

🧠
AI·MAP
AI Value Chain

From power infrastructure through compute services and models to application monetization — profiles 38 leading companies including NVIDIA, TSMC, and Microsoft across the full AI value chain.

38 Companies Primarily US GPU · Cloud · Apps
View Map
SEMI·MAP
Semi Value Chain

Full semiconductor stack from EDA, equipment, and materials through chip design, fabrication, and packaging — analyzing the competitive landscape of 20 leaders including NVIDIA, TSMC, and ASML.

20 Companies US · Taiwan EDA · Equipment · IDM
View Map
🔋
POWER·MAP
Power & Energy

AI compute demand is reshaping global energy markets. Profiles 31 power & energy companies from uranium mines to data center operators — nuclear, gas turbines, solar/wind, grid equipment and IDC REITs.

31 Companies US · HK · A-shares Nuclear · Gas · IDC
View Map
🤖
ROBO·MAP
Robotics & Auto Driving

From precision reducers, motors, and sensors to full humanoid robot systems and deployment scenarios — covers 23 companies including Tesla Optimus, UBTECH, and Unitree Robotics and the embodied AI investment thesis.

23 Companies US · HK · A-shares Humanoid · Components
View Map
⛓️
CHAIN·MAP
Blockchain & Bitcoin

From mining hashrate to stablecoins and RWA — analysis of 20 blockchain companies across US, HK & A-shares including Coinbase, Strategy, and Circle, with deep coverage of the current deep drawdown and market bifurcation.

20 Companies US · HK · A-shares Stablecoin · RWA · Mining
View Map
💊
PHARMA·MAP
Biopharma

From life science tools and CXO contract services to innovative drugs and commercialization — profiles 26 companies including Eli Lilly, Novo Nordisk, WuXi AppTec, and BeiGene, with focus on GLP-1, ADC, and global licensing themes.

26 Companies US · HK · A-shares GLP-1 · ADC · CXO
View Map